PLEASANTON, Calif.--(BUSINESS WIRE)--DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious diseases, today announced that the company has formed strategic ...
Laboratories are just beginning to assess the magnitude of operational changes needed to comply with a new federal rule expanding regulatory oversight of lab developed tests (LDTs). In a major shift, ...
Review & Outlook: CDC director Rochelle Walensky says she’s going to reshuffle the agency with an emphasis on 'action' and 'equity.' Her diagnosis and prescription are both wrong. Images: ...
SAN LEANDRO, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, ...
Many laboratories around the world have adopted expanded diagnostic testing capabilities to address the coronavirus pandemic and are now seeking ways to expand testing with additional workflows for ...
French microreactor developer Naarea announced the commissioning of its industrial test facility and laboratory, referred to as the I-Lab. It will be used to conduct non-nuclear tests and experiments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results